ASLAN Pharmaceuticals Limited Made Headway
Fri, Nov 29, 2019 at 05:30 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) shot up at $3.82, representing a gain of 64.7%. On Thu 28 Nov 19, ASLN:NASDAQ touched a New 6-Month Intraday High of $3.9. The stock appeared on our News Catalysts scanner on Fri 22 Nov 19 at 12:16 PM in the 'RECOMMENDATION' category. From Thu 07 Nov 19, the stock recorded 42.86% Up Days and 33.33% Green Days
The stock spiked on Wed 27 Nov 19 at $3.9 with a volume of 15M+.
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 64.66%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 58.17%
- Pintec Technology Holdings Limited (PT:NASDAQ), 48.89%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 37.74%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 35.65%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 34.33%
- Sequans Communications S.A. (SQNS:NYSE), 33.19%
- SORL Auto Parts, Inc. (SORL:NASDAQ), 30%
- TransAtlantic Petroleum Ltd. (TAT:NYSEMKT), 25.49%
- Novavax, Inc. (NVAX:NASDAQ), 23.1%